Cipla's anti-malaria drug receives WHO pre-qualification
PTI | 04 Oct 2012, 7:04 PMNew Delhi, Oct 4: Drug firm Cipla on Thursday said an anti-malarial drug developed by Drugs for Neglected Diseases initiative (DNDi) has received pre-qualification from the World Health Organisation (WHO).The Mumbai-headquartered firm is manufacturing the